Navigation Links
USARAD Holdings, Inc. Including Its SecondOpinions.Com® Division, Announces a Record Growth in 2016 and Launches Artificial Intelligence (AI) Innovation Lab

USARAD Holdings Inc., a leading US Joint Commission Accredited venture-backed teleradiology and telemedicine company announces significant growth last year adding 65 new US and international facilities to its client base. Some notable US customers include Veterans Authority and US Army medical centers as well as one of US largest imaging center chains. USARAD continued its global expansion strategy and has added multiple new international hospital customers from multiple countries such as Singapore and Saudi Arabia. Its® division also experienced continued growth globally, to date providing service to consumers and business customers in over 80 countries.

The company predicts an accelerated growth in 2017 and introduces additional efficiencies into its practice to deal with potential physician supply challenges. United States and many other parts of the world are experiencing a greater than ever shortage of qualified expert physicians, including radiologists. For example, the shortage of radiologists in USA became especially acute over the past 6 months. Therefore, to sustain its growth, USARAD will be deploying existing and new artificial intelligence algorithms developed jointly with its partners. USARAD’s goal is to utilize unique computer assisted technology to significantly augment its physician’s capabilities.

“By leveraging deep learning and artificial intelligence technologies USARAD is well positioned to continue its global leading position and will accelerate its quest to affordably bring high quality healthcare around the world,” explained Michael Yuz, M.D. MBA, CEO and founder of USARAD Holdings Inc.“ Dr Yuz is considered to be both the leading expert physician and serial entrepreneur in the field of Artificial Intelligence who has helped develop the algorithms as well as invested into health-related AI platforms since 2005. He added, “We are indeed very fortunate that Radiology and AI have collided and in fact, they will soon be inseparable. Furthermore, USARAD is in a very unique position since not only are we able to develop and perfect these AI algorithms, but we are also able to immediately integrate them into our production, workflows and day to day practice."

About USARAD Holding Inc. including®
USARAD Holdings, Inc. is a global telemedicine company consisting of two operating divisions – USARAD and®. USARAD is a radiology services provider offering interpretations of a full range of sub-specialty and general radiology patient studies. With an existing advanced technology network connecting medical facilities to board-certified radiologists and support staff, USARAD offers radiology services in all 50 states as well as more than 15 countries. Via its unique Radiology-On-Demand® platform, USARAD is committed to providing timely and responsive image review 24/7.® is a medical consultation and second opinions leader providing health care customers, physicians and consumers with expert opinions from all medical specialties and sub-specialties.®, which currently conducts business in more than 80 countries, also contracts with insurance companies, corporations, and medical centers of excellence. USARAD has recently received funding from the Venture Capital Unit of Siemens, Omphalos Venture Partners and Excelerate Health Ventures. For more information please visit and The company will be exhibiting at HIMSS and American Telemedicine Association conference in Orlando Feb 19-23 and April 23-25 respectively.

Carrin Harris
+1 888-886-5238 x99

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Hill-Rom Holdings, Inc. Hosts Fiscal 2016 Second Quarter Earnings Conference Call and Webcast
2. Lixte Biotechnology Holdings, Inc. Announces Exclusive Licensing Of Their Lead Anti-Cancer Compound LB-100 For Potential Treatment Of Hepatocellular Carcinoma In Asia To Taipei Medical University
3. Zimmer Biomet Holdings, Inc. Announces Quarterly Dividend for Third Quarter of 2015
4. Organovo Holdings, Inc.s Presentation at Cantor Fitzgerald Inaugural Healthcare Conference Now Available via Webcast Replay
5. Organovo Holdings, Inc. To Present at Cantor Fitzgerald Inaugural Healthcare Conference
6. Organovo Holdings, Inc. Announces Fiscal Year 2015 Earnings Conference Call
7. Theres More To Making Green With Green Products For Pacific Shore Holdings, Inc. CEO Matthew Mills
8. Pacific Shore Holdings, Inc. Retains Smith Public Relations To Assist In Marketing Of Its National Products Portfolio
9. Organovo Holdings, Inc. Reports Third Quarter Results
10. Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma
11. Organovo Holdings, Inc. to Webcast, Live, at September 11
Post Your Comments:
(Date:5/4/2019)... ... May 03, 2019 , ... Diopsys Inc, ... Diopsys® ffERG/Photopic Negative Response vision test, a new full field electroretinography (ffERG) ... estimated that 6.3 million Americans will have glaucoma, with black Americans having the ...
(Date:5/2/2019)... , ... May 02, 2019 , ... Stay on top ... medical device and food industries. Access to all webinars is free, so be sure ... in your field! , Visit to see our upcoming webinars: , ...
(Date:4/25/2019)... ... April 23, 2019 , ... Frank is an albino, deaf Great Dane. His owners rescued ... due to his health issues. Despite his hearing impairment, he was always an active and ... would play all day, every day. As the two grew, playtime became rougher and Frank ...
(Date:4/16/2019)... , ... April 16, 2019 , ... ... Sources and their project partner, the U.S. Army Center for Environmental Health Research ... Biomonitor Through Combined In-Licensing/Out-Licensing.” , Blue Sources, a veteran-owned company located at the ...
Breaking Biology Technology:
(Date:4/25/2019)... ... , ... In recent years the neurocognitive effects of treatments ... cases the magnitude of these deficits and the long-term impact on cognitive maturation ... may impact developmental trajectories, and patients are often so unwell at the time ...
(Date:4/25/2019)... ... April 24, 2019 , ... In a letter ... a broad collective of 62 individual scientists, bioethicists, and biotechnology executives, including past-presidents ... Cell Therapy (ASGCT), across industry and academia called for collaboration on a binding ...
(Date:4/25/2019)... CHESTER, Ohio (PRWEB) , ... April 25, 2019 ... ... research agents, as well as screening tools, has strengthened its commitment to meeting ... can be used in any application where inhibition of its targeted proteases is ...
Breaking Biology News(10 mins):